Bayer announced today that data from across the KERENDIA® (finerenone) comprehensive clinical trial program will be presented at the Heart Failure Society of America (HFSA)’s Annual Scientific Meeting ...

The European Society of Cardiology has recently published guidelines regarding the management of pericarditis and myocarditis.

On 15 September 2025, Regeneron Pharmaceuticals conducted a study is researching an experimental drug called REGN5381 (called ...

Ongoing research and sustained efforts are creating optimism for more effective therapies and the possibility of a cure.

Cardiovascular disease is a silent killer and a worldwide threat. According to the World Health Organization, 17-18 million ...

ASX healthcare sector struggling to find relief after weeks of weakness but Morgans’ Scott Power reckons it might finally be ...

Cardiac rehabilitation is a crucial, underutilized service for heart attack survivors, offering structured exercise programs ...

September 29 is World Heart Day, which was established by the World Heart Federation (WHF) to raise awareness about heart ...

The Department of Finance (DOF) on Saturday welcomed President Ferdinand “Bongbong” Marcos Jr.’s decision to restore the P60 ...

The Department of Finance (DOF) has voiced support for President Ferdinand R. Marcos Jr.'s decision to restore P60 billion in ...

Background Postoperative cerebral infarction following coronary artery bypass grafting (CABG) for multivessel coronary artery ...

The Company has submitted a supplemental New Drug Application (sNDA) seeking the approval of revumenib for the treatment of R/R mNPM1 AML. The sNDA has been granted Priority Review by the FDA and ...